| Cardiovascular events and intensity of treatment in polycythemia vera R Marchioli, G Finazzi, G Specchia, R Cacciola, R Cavazzina, D Cilloni, ... New England Journal of Medicine 368 (1), 22-33, 2013 | 907 | 2013 |
| Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study A Tefferi, E Rumi, G Finazzi, H Gisslinger, AM Vannucchi, F Rodeghiero, ... Leukemia 27 (9), 1874-1881, 2013 | 781 | 2013 |
| Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis) T Barbui, G Finazzi, A Carobbio, J Thiele, F Passamonti, E Rumi, ... Blood, The Journal of the American Society of Hematology 120 (26), 5128-5133, 2012 | 628 | 2012 |
| Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia AM Vannucchi, E Antonioli, P Guglielmelli, A Rambaldi, G Barosi, ... Blood, The Journal of the American Society of Hematology 110 (3), 840-846, 2007 | 613 | 2007 |
| Survival and disease progression in essential thrombocythemia are significantly influenced by accurate morphologic diagnosis: an international study. T Barbui, J Thiele, F Passamonti, E Rumi, E Boveri, M Ruggeri, ... Journal of clinical oncology 29 (23), 3179-3184, 2011 | 557 | 2011 |
| Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study G Finazzi, V Caruso, R Marchioli, G Capnist, T Chisesi, C Finelli, ... Blood 105 (7), 2664-2670, 2005 | 539 | 2005 |
| Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients A Carobbio, J Thiele, F Passamonti, E Rumi, M Ruggeri, F Rodeghiero, ... Blood, The Journal of the American Society of Hematology 117 (22), 5857-5859, 2011 | 486 | 2011 |
| A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on … F Passamonti, J Thiele, F Girodon, E Rumi, A Carobbio, H Gisslinger, ... Blood, The Journal of the American Society of Hematology 120 (6), 1197-1201, 2012 | 310 | 2012 |
| Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemia T Barbui, AM Vannucchi, V Buxhofer-Ausch, V De Stefano, S Betti, ... Blood 126 (23), 4055, 2015 | 255 | 2015 |
| Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V>F) mutation F Passamonti, ML Randi, E Rumi, E Pungolino, C Elena, D Pietra, ... Blood, The Journal of the American Society of Hematology 110 (2), 485-489, 2007 | 195 | 2007 |
| Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria G Finazzi, A Carobbio, J Thiele, F Passamonti, E Rumi, M Ruggeri, ... Leukemia 26 (4), 716-719, 2012 | 187 | 2012 |
| Masked polycythemia vera (mPV): results of an international study T Barbui, J Thiele, H Gisslinger, G Finazzi, A Carobbio, E Rumi, ... American journal of hematology 89 (1), 52-54, 2014 | 186 | 2014 |
| Acute coronary disease in essential thrombocythemia and polycythemia vera C Rossi, ML Randi, P Zerbinati, V Rinaldi, A Girolami Journal of internal medicine 243 (7), 49-53, 1998 | 153 | 1998 |
| Hydroxyurea-related toxicity in 3,411 patients with Ph'-negative MPN. E Antonioli, P Guglielmelli, L Pieri, MC Finazzi, E Rumi, V Martinelli, ... American journal of hematology 87 (5), 552-554, 2012 | 151 | 2012 |
| Genetic basis of congenital erythrocytosis: mutation update and online databases C Bento, MJ Percy, B Gardie, TM Maia, R van Wijk, S Perrotta, ... Human mutation 35 (1), 15-26, 2014 | 146 | 2014 |
| In contemporary patients with polycythemia vera, rates of thrombosis and risk factors delineate a new clinical epidemiology T Barbui, A Carobbio, E Rumi, G Finazzi, H Gisslinger, F Rodeghiero, ... Blood, The Journal of the American Society of Hematology 124 (19), 3021-3023, 2014 | 134 | 2014 |
| Initial bone marrow reticulin fibrosis in polycythemia vera exerts an impact on clinical outcome T Barbui, J Thiele, F Passamonti, E Rumi, E Boveri, ML Randi, I Bertozzi, ... Blood, The Journal of the American Society of Hematology 119 (10), 2239-2241, 2012 | 119 | 2012 |
| The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and … A Girolami, ML Randi, S Gavasso, AM Lombardi, F Spiezia Journal of thrombosis and thrombolysis 17, 139-143, 2004 | 119 | 2004 |
| Age as the major predictive factor of long‐term response to splenectomy in immune thrombocytopenic purpura F Fabris, T Tassan, R Ramon, G Carraro, ML Randi, G Luzzatto, ... British journal of haematology 112 (3), 637-640, 2001 | 113 | 2001 |
| Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIbα (Bolzano … P Noris, S Perrotta, R Bottega, A Pecci, F Melazzini, E Civaschi, S Russo, ... haematologica 97 (1), 82, 2012 | 105 | 2012 |
